New Heart-Zapping device shows promise in first human trial
NCT ID NCT06203262
First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study tested a new device called the FieldForce™ ablation system in 34 people with serious irregular heartbeats (ventricular arrhythmia). The goal was to see if the device is safe and can reduce abnormal heart rhythms. Participants had either ventricular tachycardia or frequent premature ventricular contractions. The study focused on safety and early signs of effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR ARRYTHMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IKEM
Prague, Czechia
-
Na Homolce Hospital
Prague, 150 00, Czechia
Conditions
Explore the condition pages connected to this study.